Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Taprogge

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2019
Compartmental Model for <sup>223</sup>Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate CancerJan Taprogge, Iain Murray, Jonathan Gear, et al.
Thyroid : Official Journal of the American Thyroid Association|October 2, 2021
A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' DiseaseJan Taprogge, Paul M D Gape, Lily Carnegie-Peake, et al.
EJNMMI Physics|October 8, 2020
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD projectJan Taprogge, Francesca Leek, Tino Schurrat, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 1, 2026
Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC)Minal Padden-Modi, Jan Taprogge, Peter Dutey-Magni, et al.
Frontiers in Nuclear Medicine|October 9, 2024
Initial results of the INSPIRE clinical trial-investigating radiation dosimetry for differentiated thyroid cancer patientsJan Taprogge, Carla Abreu, Lenka Vávrová, et al.
Physics in Medicine and Biology|May 9, 2025
A validation protocol for<sup>177</sup>Lu-SPECT image quantification as a basis for multi-centre kidney dosimetryLovisa Jessen, Selma Curkic Kapidzic, Johan Gustafsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid CancerJan Taprogge, Carla Abreu, Siraj Yusuf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2019
Compartmental Model for <sup>223</sup>Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate CancerJan Taprogge, Iain Murray, Jonathan Gear, et al.
Thyroid : Official Journal of the American Thyroid Association|October 2, 2021
A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' DiseaseJan Taprogge, Paul M D Gape, Lily Carnegie-Peake, et al.
EJNMMI Physics|October 8, 2020
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD projectJan Taprogge, Francesca Leek, Tino Schurrat, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 1, 2026
Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC)Minal Padden-Modi, Jan Taprogge, Peter Dutey-Magni, et al.
Frontiers in Nuclear Medicine|October 9, 2024
Initial results of the INSPIRE clinical trial-investigating radiation dosimetry for differentiated thyroid cancer patientsJan Taprogge, Carla Abreu, Lenka Vávrová, et al.
Physics in Medicine and Biology|May 9, 2025
A validation protocol for<sup>177</sup>Lu-SPECT image quantification as a basis for multi-centre kidney dosimetryLovisa Jessen, Selma Curkic Kapidzic, Johan Gustafsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid CancerJan Taprogge, Carla Abreu, Siraj Yusuf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
Pageof 2